CITADEL ADVISORS LLC 13D and 13G filings for MoonLake Immunotherapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
CITADEL ADVISORS LLC | 2,034,260 3.400% |
-851,832 (-29.52%) |
Filing |
| 2023-02-14 08:26 am Purchase |
2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
CITADEL ADVISORS LLC | 2,886,092 7.400% |
2,886,092 (New Position) |
Filing |